CalAmp reports decline in revenues
Internet of Things provider CalAmp, which has operations in Oxnard, announced a decline in revenues for its fiscal year 2018 first quarter, ended May 31, and net losses flat to the previous first quarter at $2.7 million. Revenues fell 3 percent to $88.1 million, primarily as a factor of the closing of the company’s satellite Read More →
Activist investor demands sale or merger of Deckers Brands
Story updated at 2:20 p.m.: A second activist investor penned an open letter to Deckers Brands on June 27, demanding the sale of the company or changes to the board of directors as a result of declining share values. Marcato stated in the letter that it owns 6 percent of the Goleta footwear company’s outstanding Read More →
PennyMac Mortgage Investment Trust announces cash dividend
Westlake Village-based PennyMac Mortgage Investment Trust announced a cash dividend to shareholders of record as of July 13. The real estate investment trust will pay 47 cents per common share on July 27.
MannKind moving to former Kythera space in Westlake Village
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Oxnard’s CalAmp partners with Autobrain
Internet of Things provider CalAmp, with operations in Oxnard, announced a partnership with Boca Raton, Fla-based Autobrain. Autobrain’s platform will use CalAmp’s networks to bring smart car capabilities to regular vehicles, according to the June 22 news release. Devices like OBD sensors and telematics systems will enable consumers to track their car’s location and condition Read More →
PennyMac to buy back $50 million of Class A common stock
PennyMac Financial Services announced on June 21 that it will repurchase up to $50 million of its Class A common stock. The number and timing of the purchases will depend on price, trading volume and market conditions, among other factors, the Moorpark-based company said in a statement. “We believe that the repurchase of common stock Read More →
SerImmune gets $8 million in financing from Illumina Ventures
Santa Barbara immunotherapy and diagnostic company SerImmune received $8 million in financing from San Francisco-based Illumina Ventures to expand its immune mapping platform and database. Illumina invests primarily in early-stage companies researching genomics, life science and health care. A subsidiary of pharmaceutical giant Merck also participated in the financing round, alongside other undisclosed investors. Mapping Read More →
